Latest in Finance

Samsung Biologics to acquire PolyPeptide in $1.8bn deal

The manufacturer is set to acquire peptide CDMO PolyPeptide for CHF 1.46bn, expanding its manufacturing capabilities into peptide APIs and strengthening its global footprint across the US, Europe and India

Find out more
Samsung Biologics to acquire PolyPeptide in $1.8bn deal

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

FPT launches MediSight AI framework to accelerate pharma digital transformation and regulatory compliance

The new AI-powered platform combines autonomous digital workers, interoperable healthcare data and compliance tools to help pharmaceutical manufacturers, medical device...
See more
Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Mission Therapeutics divests acute kidney injury drug MTX652 in $292m Dimerix deal

Cambridge-based biotech Mission Therapeutics has divested its Phase II-ready USP30 inhibitor MTX652 to renal specialist Dimerix in a deal worth up to $292m, allowing the company to accelerate its Parkinson’s disease pipeline
Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

Johnson & Johnson to spend up to $750m restructuring pharmaceutical supply chain

The pharma giant is consolidating parts of its manufacturing network as it advances a $55bn US investment programme aimed at expanding domestic production of advanced medicines
Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

Leica Biosystems acquires StatLab to strengthen anatomic pathology and AI-enabled cancer diagnostics

The deal adds StatLab's 50-year histology workflow portfolio to Leica Biosystems' computational pathology platform, supporting laboratory standardisation for AI-driven cancer diagnostics at scale
Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

Inflexion acquires German medical consumables specialist Primed to accelerate global expansion

The private equity firm has agreed to acquire Germany's Primed Group, backing investment in medical consumables manufacturing, sterilisation services and international growth
Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Brenntag Pharma signs exclusive European distribution agreement with Evonik for REXIM GMP amino acids

Agreement strengthens Brenntag’s position in biopharma and API markets in Europe
Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

Codis acquires Catalent's Nottingham site to become Europe's leading end-to-end spray dry provider

The deal pairs Nottingham's OSD development and clinical supply expertise with Codis' commercial-scale Haverhill facility, offering pharma partners an integrated ASD development-to-manufacture pathway within a single quality system
Novartis to acquire ADC biotech Myricx Bio for $1.5bn

Novartis to acquire ADC biotech Myricx Bio for $1.5bn

The pharma giant will add the biotech's novel NMTi payload platform to its roster, which may have potential in multiple solid tumour settings and overcome issues that have troubled ADC therapies, such as payload resistance and tolerability
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence

Latest posts in Finance

AlzeCure enters an outlicensing and collaboration agreement with QuantumCell ApS

AlzeCure enters an outlicensing and collaboration agreement with QuantumCell ApS

AlzeCure will receive an upfront payment of $12m, with additional development and commercial milestone payments and royalties
Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

The expansion enables Icosagen to support biotechnology and biopharmaceutical companies globally across discovery, developability assessment, CMC development and Phase I/II GMP manufacturing within one integrated organisation at a single site
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable supply of off-patent pharmaceuticals
Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Investment supports Lonza’s position in the ADC space by further developing its integrated ADC offering and expanding commercial-scale supply of highly potent payload-linker molecules
SCHOTT Pharma invests in sterile cartridge production in Hungary

SCHOTT Pharma invests in sterile cartridge production in Hungary

SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary
Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

The deal will add proteomics, spatial biology and cell therapy manufacturing technologies to Merck's Process Solutions business, with $140m in annual synergies targeted by year three
Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Located in one of Europe’s leading life sciences hubs, the Zurich facility serves as a key component of the company’s global bioanalytical network.
Clean Cells acquires Stem Genomics to expand cell therapy QC

Clean Cells acquires Stem Genomics to expand cell therapy QC

French biopharma QC specialist Clean Cells has bought Stem Genomics, adding genomic stability testing for stem cell therapies and strengthening its US footprint in Durham, North Carolina
Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

The financing supports a European CTA filing with the EMA for arteriovenous fistula maturation failure in end-stage kidney disease, expanding APAC's clinical programme across thrombo-inflammatory indications
ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn

Sponsor content

Lonza and Engitix announce license agreement to advance targeted ADC Development

Lonza and Engitix announce license agreement to advance targeted ADC Development

Lonza grants Engitix target-specific license for GlycoConnect, HydraSpace and SYNtecan E linker-payload technologies for ADC development
Gerresheimer publishes 2025 annual and consolidated financial statements

Gerresheimer publishes 2025 annual and consolidated financial statements

Stable revenue in a challenging financial year
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity...
Almac group delivers record year of growth

Almac group delivers record year of growth

Revenue rises to £1.1 billion as profit increases 16% and workforce expands to more than 7,900 amid continued global investment programme
Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

Andelyn Biosciences launches LVV Curator platform, bringing proven viral vector platform pedigree to Lentiviral Vector manufacturing for cell therapies

New platform leverages the established Curator platform methodology to industrialise Lentivirus processes from concept to clinic
Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...
Syngene strengthens leadership team with two key appointments to support next phase of growth

Syngene strengthens leadership team with two key appointments to support next phase of growth

Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing...
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair

Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to...
Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Lonza completes transformation to pure-play CDMO with agreement to divest Capsules & Health Ingredients

Sale of CHI business to Lone Star funds marks final step in Lonza’s strategic shift to a focused CDMO model
Piramal Pharma Limited announces results for Q3 and 9M FY26

Piramal Pharma Limited announces results for Q3 and 9M FY26

Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated...
Almac announces multi-million-pound investment in Singapore

Almac announces multi-million-pound investment in Singapore

Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country
CARBOGEN AMCIS secures refinancing to support growth and investment

CARBOGEN AMCIS secures refinancing to support growth and investment

CARBOGEN AMCIS today announced the successful refinancing and enhancement of its credit facilities through the banking syndication led by UBS Switzerland AG